Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968978044> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W1968978044 endingPage "970" @default.
- W1968978044 startingPage "969" @default.
- W1968978044 abstract "Cost is now a factor in selecting treatmentThe introduction of biological agents into the therapeutic armamentarium for rheumatoid arthritis (RA) has ushered in a new era for rheumatologists in more ways than one. Randomised controlled trials (RCTs) and longitudinal observational studies provide clear evidence that the use of these agents is associated with a greater proportion of responders and a better response than with conventional disease modifying antirheumatic drugs (DMARDs) such as methotrexate (MTX).1–9 However, these drugs are substantially more expensive than conventional DMARDs. This means that, whether we like it or not (and most of us don’t like it), cost is now one of the factors we have to consider when selecting treatment for patients with RA. Perhaps for the first time rheumatologists are having to take part in the process of healthcare policy making and endeavour to understand the language of cost effectiveness analysis (CEA). CEA compares the incremental cost of an intervention (in this case anti-tumour necrosis factor α (TNFα) therapy) over the cost of conventional treatment with its incremental health benefit.10The paper published in this issue of the Annals by Bansback et al is based on a CEA funded by Abbott Laboratories, the manufacturers of adalimumab, for submission to the Swedish Government.11 It is to be welcomed that the work is published in an academic peer reviewed journal because health economic modelling is as much a legitimate scientific endeavour as the RCTs which led to the drug being licensed.The first question posed by healthcare purchasers when …" @default.
- W1968978044 created "2016-06-24" @default.
- W1968978044 creator A5027951754 @default.
- W1968978044 date "2005-07-01" @default.
- W1968978044 modified "2023-09-26" @default.
- W1968978044 title "Anti-tumour necrosis factor therapy: can we afford it?" @default.
- W1968978044 cites W1979364075 @default.
- W1968978044 cites W1985763670 @default.
- W1968978044 cites W2014937111 @default.
- W1968978044 cites W2046628605 @default.
- W1968978044 cites W2097585904 @default.
- W1968978044 cites W2098767548 @default.
- W1968978044 cites W2116843833 @default.
- W1968978044 cites W2133541603 @default.
- W1968978044 cites W2134363311 @default.
- W1968978044 cites W2149338618 @default.
- W1968978044 cites W2314052274 @default.
- W1968978044 cites W2319957449 @default.
- W1968978044 cites W2394507607 @default.
- W1968978044 cites W2396296965 @default.
- W1968978044 cites W2413901462 @default.
- W1968978044 cites W2438063247 @default.
- W1968978044 doi "https://doi.org/10.1136/ard.2005.037564" @default.
- W1968978044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1755573" @default.
- W1968978044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15958756" @default.
- W1968978044 hasPublicationYear "2005" @default.
- W1968978044 type Work @default.
- W1968978044 sameAs 1968978044 @default.
- W1968978044 citedByCount "6" @default.
- W1968978044 crossrefType "journal-article" @default.
- W1968978044 hasAuthorship W1968978044A5027951754 @default.
- W1968978044 hasBestOaLocation W19689780441 @default.
- W1968978044 hasConcept C126322002 @default.
- W1968978044 hasConcept C143998085 @default.
- W1968978044 hasConcept C17991360 @default.
- W1968978044 hasConcept C203014093 @default.
- W1968978044 hasConcept C502942594 @default.
- W1968978044 hasConcept C503630168 @default.
- W1968978044 hasConcept C71924100 @default.
- W1968978044 hasConceptScore W1968978044C126322002 @default.
- W1968978044 hasConceptScore W1968978044C143998085 @default.
- W1968978044 hasConceptScore W1968978044C17991360 @default.
- W1968978044 hasConceptScore W1968978044C203014093 @default.
- W1968978044 hasConceptScore W1968978044C502942594 @default.
- W1968978044 hasConceptScore W1968978044C503630168 @default.
- W1968978044 hasConceptScore W1968978044C71924100 @default.
- W1968978044 hasIssue "7" @default.
- W1968978044 hasLocation W19689780441 @default.
- W1968978044 hasLocation W19689780442 @default.
- W1968978044 hasLocation W19689780443 @default.
- W1968978044 hasLocation W19689780444 @default.
- W1968978044 hasLocation W19689780445 @default.
- W1968978044 hasOpenAccess W1968978044 @default.
- W1968978044 hasPrimaryLocation W19689780441 @default.
- W1968978044 hasRelatedWork W1504336579 @default.
- W1968978044 hasRelatedWork W192572016 @default.
- W1968978044 hasRelatedWork W1993337080 @default.
- W1968978044 hasRelatedWork W1998491594 @default.
- W1968978044 hasRelatedWork W2078342206 @default.
- W1968978044 hasRelatedWork W2086591120 @default.
- W1968978044 hasRelatedWork W2146828847 @default.
- W1968978044 hasRelatedWork W2297299410 @default.
- W1968978044 hasRelatedWork W2366923372 @default.
- W1968978044 hasRelatedWork W643060184 @default.
- W1968978044 hasVolume "64" @default.
- W1968978044 isParatext "false" @default.
- W1968978044 isRetracted "false" @default.
- W1968978044 magId "1968978044" @default.
- W1968978044 workType "article" @default.